Document Detail


Assessment of CA-125 area under the curve as a prognostic factor in patients with ovarian cancer.
MedLine Citation:
PMID:  23322523     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The goal of this study was to evaluate the efficacy of CA-125 area under the curve (CA-125 AUC) as a prognostic factor following surgical treatment for ovarian cancer patients. A retrospective analysis was conducted on ninety-five patients with ovarian cancer who had primary treatment in a tertiary center between 2000 and 2010. After either optimal or cytoreductive surgery, all patients underwent adjuvant chemotherapy. CA-125 AUC was calculated for each patient that had a minimum of three CA-125 serum measurements during the treatment period. The mean age at diagnosis and mean survival were 53.9 years (range, 16-75 years) and 35.6 ± 22.9 months (range, 3.1-95.4 months), respectively. The mean (and median) CA-125 AUC of patients of FIGO stages I, II, III, and IV was 53.0 (42.5), 58.06 (58.06), 97.8 (54.6), and 405.2 (149.3) IU/ml day, respectively (p = 0.004). The mean CA-125 AUC was 57.7, 410.1, and 636.3 IU/ml day for patients with a complete response, partial response, and no response/progressive disease to first-line chemotherapy, respectively (p < 0.001). The CA-125 AUC cut-off level for an overall survival of ≥5 years was 99.75 IU/ml day with a sensitivity of 90.9 % (95 % CI, 70.8-98.6) with 1.27 as positive likelihood ratio. Patients who suffer from ovarian cancer, with a lower CA125 AUC, have a better overall survival than those with a higher CA125 AUC. CA-125 AUC could be used as an independent factor for evaluating the treatment efficacy and chemotherapy response.
Authors:
Sernaz Uzunoglu; Aysun Aybatlı; Petek Balkanlı Kaplan; Irfan Cicin; Necdet Sut; Cenk Sayın; Fusun Varol
Related Documents :
15908663 - Molecular staging for survival prediction of colorectal cancer patients.
23889653 - Predicting survival of endoscopic gastrostomy candidates using the underlying disease, ...
18222623 - A comparison of right and extended right hepatectomy with all other hepatic resections ...
Publication Detail:
Type:  Journal Article     Date:  2013-01-16
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  447     Citation Subset:  IM    
Affiliation:
Department of Medical Oncology, Trakya University Faculty of Medicine, 22030, Edirne, Turkey, sernaz.uzunoglu@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer pa...
Next Document:  Sequential docetaxel as adjuvant chemotherapy for node-positive or/and T3 or T4 breast cancer: clini...